Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine

NCT03281694 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT03281694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03281694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 1
Overall status
Withdrawn
Start date
May 31, 2018
Completion date
February 28, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive change